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Available methods for differentiating human embry-
onic stem cells (ESCs) and induced pluripotent cells
(iPSCs) into neurons are often cumbersome, slow,
and variable. Alternatively, human fibroblasts can
be directly converted into induced neuronal (iN) cells.
However, with present techniques conversion is inef-
ficient, synapse formation is limited, and only small
amounts of neurons can be generated. Here, we
show that human ESCs and iPSCs can be converted
into functional iN cells with nearly 100% yield and pu-
rity in less than 2 weeks by forced expression of a
single transcription factor. The resulting ES-iN or
iPS-iN cells exhibit quantitatively reproducible prop-
erties independent of the cell line of origin, form
mature pre- and postsynaptic specializations, and
integrate into existing synaptic networks when trans-
planted into mouse brain. As illustrated by selected
examples, our approach enables large-scale studies
of human neurons for questions such as analyses of
human diseases, examination of human-specific
genes, and drug screening.
INTRODUCTION
The generation of human embryonic stem cells (ESCs) and
induced pluripotent stem cells (iPSCs) and their in vitro differen-
tiation into potentially any desired cell type hold great promise
and may revolutionize the study of human disease (Hanna
et al., 2010; Okita and Yamanaka, 2011; Blanpain et al., 2012).
Given the lack of alternative sources, a major effort has been
directed toward the development of differentiation protocols
that convert pluripotent stem cells into neurons to allow exami-
nation of healthy human neurons and of neurons derived from
patients with a variety of neurological diseases. In this approach,
fibroblasts frompatients with poorly understood diseases—suchas schizophrenia or Alzheimer’s disease—are converted into
iPSCs that are then differentiated into neurons to study the path-
ogenesis of these diseases (reviewed in Han et al., 2011; Ming
et al., 2011; Brennand et al., 2012; Marchetto and Gage 2012).
Moreover, elegant studies have described differentiation proto-
cols that produce distinct types of neurons in vitro, although
the number and properties of different types of human neurons
in situ are largely unknown and are only now beginning to be
defined. Overall, these studies suggest that derivation of neurons
from human stem cells may allow scientists to examine specific
subtypes of neurons, to generate human neurons for regenera-
tive medicine, and to investigate changes in human neurons in
neuropsychiatric disorders (e.g., see Cho et al., 2008; Fasano
et al., 2010; Kriks et al., 2011; Shi et al., 2012; Chambers et al.,
2012; Ma et al., 2012). However, this approach of studying hu-
man neurons at present suffers from two major limitations.
The first limitation is based on characteristic differences be-
tween particular pluripotent cell lines (Osafune et al., 2008; Hu
et al., 2010; Bock et al., 2011). These differences influence the
properties of the neurons that are derived from these lines. For
example, neurons derived by the same protocol from two
different ESC lines exhibited quite distinct properties (Wu et al.,
2007). Moreover, ESC and iPSC lines may change as a function
of time in culture (Mekhoubad et al., 2012). A comparison of
the neural differentiation potential of different ESC and iPSC
lines revealed a large variation in differentiation efficiency, and
it is likely that maturation stages and functional properties of
the resulting neurons are also variable (Hu et al., 2010).
The second limitation is related to the cumbersome, variable,
and slow procedures needed for deriving neurons with functional
properties from ESCs or iPSCs. Generating neurons by differen-
tiation of ESCs or iPSCs requires months of tissue culture proce-
dures and renders large-scale studies difficult (Johnson et al.,
2007). Moreover, differentiation of ESCs and iPSCs into neurons
depends on specific environmental factors such as pharmaco-
logical agents and bioactive proteins that may be difficult to
obtain with a consistent composition, injecting a further element
of variation (Soldner and Jaenisch, 2012).
The two major limitations of current technologies for gener-
ating human neurons outlined above motivated us and othersNeuron 78, 785–798, June 5, 2013 ª2013 Elsevier Inc. 785
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Figure 1. Rapid Single-Step Generation of
Human iN Cells
(A) Design of lentiviral vectors for Ngn2-mediated
conversion of ESCs and iPSCs to iN cells. Cells are
transduced with (1) a virus expressing rtTA and (2)
either a single additional virus expressing an Ngn2/
EGFP/puromycin resistance gene as a fusion
protein linked by P2A and T2A sequences, or with
two viruses that separately express Ngn2/puro-
mycin resistance gene and EGFP.
(B) Flow diagram of iN cell generation.
(C) Representative images illustrating the time
course of the conversion of H1 ESCs into iN cells.
Corresponding differential interference contrast
(DIC) and GFP fluorescence pictures are shown on
top and bottom.
(D) Representative images of converted iN cells
from two different iPSC lines at day 6 and day 14.
Note that iN cells are clearly identifiable already on
day 6. For iN cells generated with NeuroD1
expression, see Figure S1.
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Generation of Human Neurons for Synapse Analysisto develop methods for direct conversion of human fibroblasts
into induced neurons, referred to as iN cells (Pang et al., 2011;
Ambasudhan et al., 2011; Qiang et al., 2011; Pfisterer et al.,
2011a, 2011b; Yoo et al., 2011; Caiazzo et al., 2011; Son et al.,
2011). Although these efforts were successful and allow rapid
production of human iN cells, all of the currently available proto-
cols for generating human iN cells (as opposed tomouse iN cells)
suffer from relatively low yields and low efficiency and are further
hampered by the limited availability and renewability of fibro-
blasts as starting materials. Moreover, the resulting iN cells often
exhibited decreased competence for synapse formation. Specif-
ically, we (Pang et al., 2011) and others (Pfisterer et al., 2011a;
Son et al., 2011) found that the same three transcription factors
that convert mouse fibroblasts into iN cells (Brn2, Ascl1, and
MytL1; Vierbuchen et al., 2010) also transdifferentiate human fi-
broblasts into iN cells when combined with a fourth transcription
factor (NeuroD1), a process that may be additionally facilitated
by coexpression of microRNAs (Yoo et al., 2011; Ambasudhan
et al., 2011). However, apart from the limited capabilities of iN
cells produced by these procedures, these experiments did
not clarify theminimal requirement of defined factors for transdif-786 Neuron 78, 785–798, June 5, 2013 ª2013 Elsevier Inc.ferentiating human nonneuronal cells into
neurons and suggested that ancillary fac-
tors, such as specific culture conditions,
may introduce further variability into these
transdifferentiation protocols. Together,
these features make analysis of disease-
related phenotypes using human iN cells
difficult, especially since these protocols
do not generate large amounts of iN cells
that are fully competent to form
synapses.
To address these problems, we here
developed approaches that allow rapid
and reproducible production of human
iN cells from ESCs or iPSCs. The experi-
ments we describe utilize a renewableresource and are scalable and result in iN cells with reproducible
properties that are independent of the starting ESC or iPSC line.
Strikingly, our approach requires only a single transcription fac-
tor and generates large amounts of human iN cells with robust
synapse formation capabilities. Moreover, we demonstrate that
the resulting iN cells can be used for analysis of human neuronal
short-term plasticity, large-scale Ca2+-imaging, or analysis of
loss-of-function states mimicking a human genetic disorder.
Thus, the approach we describe may be generally useful not
only to explore the cellular phenotype associated with neuropsy-
chiatric disorders, but also for drug screening endeavors and for
mechanistic studies.
RESULTS
A Single Transcription Factor Efficiently Converts
Human ESCs and iPSCs into Neurons
Following our initial observation that the combined expression of
Brn2, Ascl1, and MytL1 induces functional neurons from human
ESCs (Pang et al., 2011), we examined whether forced expres-
sion of a series of single transcription factors in ESCs and iPSCs
Table 1. Comparison of the Rapid iN Cell Generation Method Presented Here with Previously Reported Methods of Generating
Neurons from ESCs/iPSCs
Targeted Cell Type
Time to Tuj1/
MAP2+ Cells
Time to
Functional
Synapses
Yield of
Neurons
Neuronal
Purity
Neuron
Subtype
Purity Reference PMID
Neurons 6 weeks 12 weeks ND 15–79%* Mixed Hu et al., 2010 20160098
NPCs 4–5 weeks ND ND ND Mixed Zhang et al., 2001 11731781
Neurons 4 weeks 7 weeks ND 89 ± 3%* Mixed Johnson et al., 2007 17376968
NPCs 3 weeks ND ND 82%* Mixed Chambers et al., 2009 19252484
NPCs 3–4 weeks ND ND ND Mixed Elkabetz et al., 2008 18198334
Nociceptive sensory neurons 2 weeks ND ND >75%* >60% ** Chambers et al., 2012 22750882
Midbrain dopamine neurons 3–4 weeks >7 weeks ND ND 60%–80%** Kriks et al., 2011 22056989
NPCs 4 weeks ND ND 40–70%* mixed Koch et al., 2009 19218428
Cortical excitatory neurons 3–4 weeks >8 weeks ND 40% * <20%** Espuny-Camacho et al., 2013 23395372
Neurons 4 weeks 5 weeks with
glia coculture
ND 70–80%* mixed Wu et al., 2007 17693548
Inhibitory forebrain neurons 3–4 weeks 6 weeks ND 70% ** 80%** Maroof et al., 2013 23642365
Inhibitory forebrain neurons 3–4 weeks 8 weeks with
glia coculture
ND 92% ** 76%** Nicholas et al., 2013 23642366
Neurons 3–4 weeks 4–5 weeks ND 90% ** mixed Israel et al., 2012 22278060
Excitatory neurons 1 week 2 weeks 100%** 100%** 100%*** this study n.a.
*Based on 1 marker expression, ** based on multiple markers, ***based on functional data. All time periods listed are from the undifferentiated ESC
state; ND: not determined.
Neuron
Generation of Human Neurons for Synapse Analysismight initiate iN cell differentiation. As in previous studies (Vier-
buchen et al., 2010; Pang et al., 2011), we used lentiviral delivery
for constitutive expression of rtTA (Urlinger et al., 2000) and
tetracycline-inducible expression of exogenous proteins driven
by a tetO promoter. Surprisingly, we found that overexpressing
either neurogenin-2 (Ngn2) or NeuroD1 alone rapidly converted
ESCs and iPSCs into neuronal cells (Figure 1 and Figure S1,
available online). Since this conversion was based on forced
expression of a lineage-specific transcription factor and appears
to be a direct lineage conversion similar to lineage conversion
between somatic cells, we refer to the resulting neurons as iN
cells as previously (Vierbuchen et al., 2010; Pang et al., 2011).
Because the effects of NeuroD1 and Ngn2 were similar, we
decided to focus only on one factor and chose Ngn2. To selec-
tively culture only cells expressing the transcription factor, we
coexpressed a puromycin resistance gene with Ngn2 (allowing
us to select for cells expressing Ngn2), and we additionally coex-
pressed EGFP (allowing us to identify lentivirally transduced
cells). In the standard protocol (Figure 1A), ESCs or iPSCs
were plated on day 2, the cells were infected with lentiviruses
on day 1, and Ngn2 expression was induced with doxycyclin
on day 0. A 24 hr puromycin selection period was started on
day 1, and mouse glia (primarily astrocytes) were added on
day 2 to enhance synapse formation (Figure 1B; Vierbuchen
et al., 2010). Strikingly, forced Ngn2 expression converted
ESCs and iPSCs into neuron-like cells in less than 1 week and
produced an apparently mature neuronal morphology in less
than 2 weeks (Figures 1C and 1D). This is faster than any
currently available method for generating neurons from human
ESCs or iPSCs (Table 1).
We stained H1 ESCs and H1-derived iN cells at 21 days after
induction for EGFP (to identify cells with viral transduction), thestem cell markers Sox2, Oct4, and Nanog, and the glial cell
marker GFAP (tomarkmouse astrocytes added to the iN cell cul-
ture for promotion of synapse formation). At the level of immuno-
labeling, expression of stem cell markers was abolished in iN
cells, consistent with a conversion of H1 ESCs into iN cells (Fig-
ure 2A). Quantitative RT-PCR analyses revealed that iN cells ex-
pressed increased levels of endogenous Ngn2 as well as of two
neuronal markers, NeuN and MAP2, whose levels were elevated
100-fold (Figure 2B). In addition, we observed an even larger in-
duction of the expression of the transcription factors Brn2 and
FoxG1, which are markers for excitatory cortical neurons
(Figure 2B).
Immunoblotting experiments showed that the neuronal pre-
cursor cell (NPC) markers nestin and Sox2 were only detectable
in the ESCs and iPSCs, whereas a series of well-established syn-
aptic genes were only expressed in 3-week-old Ngn2 iN cells
(Figures 2C and S2A). Quantitative RT-PCR measurements of
the expression of the NPC markers Sox2 and nestin in the first
2 weeks after Ngn2 induction revealed a transient brief increase
in thesemarkers immediately after induction, with a rapid decline
in expression (Figure S2B). Furthermore, upon coculture with
mouse astrocytes, H1-cell-derived iN cells formed synapses
with each other andwith cocultured COS cells expressing neuro-
ligin-1 (Figures S2C–S2E). Thus, iN cell generation involves a
switch from a stem cell to a neuronal gene expression phenotype
with stimulation of endogenous Ngn2 expression.
Measurements of the yield of iN cell conversion in three stem
cell lines, H1 ESCs and two different iPSC lines, showed that
nearly 100% of surviving lentivirally infected ESCs and iPSCs
were converted into neurons, revealing an unprecedented effi-
ciency of conversion (Figure 2D). When we calculated the num-
ber of iN cells generated as a function of starting ESCs or iPSCs,Neuron 78, 785–798, June 5, 2013 ª2013 Elsevier Inc. 787
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Figure 2. Characterization of the Properties and Yield of Ngn2-Generated iN Cells
(A) Immunofluorescence images of H1 ESCs and H1 ESC-derived iN cells (3 weeks after induction). H1 ESCs but not iN cells are positive for the ESC markers
Nanog, Sox2, and Oct4, while GFAP is only present in cocultured astrocytes but not iN or ESCs.
(B) Quantification of selected mRNA levels in H1 ESCs and in H1 ESC-derived iN cells after 2 and 3 weeks of lentiviral infection. Levels are normalized for GAPDH
mRNA levels as an internal control and are shown on a logarithmic scale. Note that endogenous Ngn2 is induced20-fold, and endogenous Brain-2 and FOXG1
expression is induced > 1,000-fold. Data are means ± SEM (n = 3 independent experiments).
(C) Immunoblot analyses of proteins extracted from human postmortem cortex (hu Brain), mouse brain (m Brain), and cultured mouse glia cells (m Glia) and of
proteins solubilized from iN cells that were derived from H1 ESC and two different iPSC lines (3 weeks after induction) and from the starting ESCs and iPSCs as
indicated. Proteins are identified on the left (Cpx1/2, complexin-1 and2; Syb2, synaptobrevin-2; Syt1, synaptotagmin-1; Syn1, synapsin-1; Synt1A/B, syntaxin-
1A and -1B).
(D) Representative images of H1 ESC-derived iN cells visualized via their EGFP fluorescence and immunolabeled for MAP2 or NeuN as indicated.
(legend continued on next page)
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Generation of Human Neurons for Synapse Analysiswe observed an apparent increase with H1 ESC-derived iN cells
but not with the two iPSC-line-derived iN cells (Figure 2D). The
increase in cell numbers in H1 ESC-derived iN cells is due to
the continuing division of H1 cells after plating; iPS-cell derived
iN cells do not show such increased cell numbers because
they exhibit some cell death in response to culture splitting and
lentiviral infection, resulting in a partial loss of the iPSCs as iN
cells are being generated. Overall, these data demonstrate that
forced expression of a single transcription factor—Ngn2—in-
duces neuronal differentiation with high yield.
ESC- and iPSC-Derived iN Cells Exhibit Reproducible
Gene Expression Patterns
We next aimed to gain insight into the nature of the neurons
generated and, more importantly, to assess the reproducibility
of Ngn2-induced production of iN cells from different ESC and
iPSC lines. Toward this end, we quantitatively analyzed expres-
sion of 73 genes at the single-cell level using fluidigm-dependent
mRNA measurements (Pang et al., 2011; Table S1). All fluidigm-
mediated quantitative RT-PCR assays were validated using
standard curves (Table S1). Analysis of more than 100 individual
iN cells revealed a uniform but discrete pattern of gene expres-
sion in iN cells derived from H1 ESC and two different iPSC lines
(Figures 3 and S3). Specifically, Ngn2-iN cells expressed at high
levels the telencephalic markers Brn-2, Cux1, and FoxG1, which
are characteristic of layer 2/3 excitatory cortical neurons, but
lacked other prominent forebrain transcription factors (e.g.,
Tbr1 and Fog2). iN cells consistently expressed AMPA-type
glutamate receptors GluA1, A2, and A4, but lacked NMDA-
type glutamate receptors 3 weeks after induction (Figure 3A).
Moreover, nearly all iN cells expressed vGlut2, and approxi-
mately 20% of iN cells expressed vGlut1. iN cells highly ex-
pressed GABAA receptors but lacked the vesicular GABA trans-
porter vGAT or the GABA-synthetic enzyme glutamate
decarboxylase (GAD). Ngn2 iN cells expressed all panneuronal
markers tested, but lacked expression of markers for various
glia cell types or for stem cells (Figures 3A and S3B). Thesemea-
surements show that Ngn2 iN cells are relatively homogeneous
and that they constitute excitatory neurons that express telence-
phalic markers suggestive of cortical layers 2/3.
Arguably the most important question in the production of iN
cells—in fact, in the in vitro production of all human neurons—
is reproducibility between lines. We therefore assessed this
question for the Ngn2-based protocol in great detail. Compari-
son of the gene expression profiles between iN cells produced
by forced differentiation of H1 ESCs and of two independent
lines of iPSCs revealed a striking concordance in expression
patterns (Figures 3B and S3D). There was no major difference
between stem cells in the expression of the genes tested. The
highly similar transcriptional effects of Ngn2 indicate that forced
expression of Ngn2 can override presumptive epigenetic differ-
ences between various pluripotent stem cell lines to induce dif-(E) Yield of iN cell conversion of H1 ESCs and two different iPSC lines. The percen
or 3 weeks of conversion is shown on the left, and the yield of NeuN-positive c
percentage of EGFP-positive cells (dark bars) or in terms of starting cell numbers
derived iN cells because H1 cells still proliferate after lentiviral infection, while iPSC
are means ± SEMs (n = 3 independent experiments). For additional data, see Figferentiation of a single homogenous population of excitatory
forebrain neurons.
Human ESC- and iPSC-Derived iN Cells Form Synapses
We next probed the ability of Ngn2-induced iN cells to differen-
tiate into electrophysiologically active neurons and to form syn-
apses. To promote synapse formation, we cocultured iN cells
with mouse glial cells (Pang et al., 2011). The iN cells reliably pro-
duced robust action potentials, and exhibited voltage-gated Na+
and K+ currents that were indistinguishable between iN cells
derived from H1 ESC and different iPSC lines (Figures 4A–4C
and S4A). iN cells exhibited massive spontaneous synaptic ac-
tivity that was blocked by the AMPA-receptor antagonist
CNQX (Figure 4D). Extracellular stimulation evoked EPSCs of
large amplitudes, documenting abundant synapse formation
(Figures 4E and 4F). The kinetics of evoked EPSCswere identical
at 70 mV and +40 mV holding potentials, and EPSCs were
blocked by CNQX at both holding potentials. Thus, consistent
with the gene expression profile described in Figure 3A, EPSCs
are entirely due to activation of AMPA-type and not of NMDA-
type glutamate receptors, although we did observe small
NMDA-receptor mediated synaptic currents in iN cells after
more than 3 weeks of culture (Figure S4B). When we quantified
the frequency and amplitude of spontaneous EPSCs and the
amplitude of evoked EPSCs, we found that they were indistin-
guishable between iN cells derived from H1 ESCs and two
different iPSC lines and were reproducible between experiments
(Figure 4G).
Stimulus trains of 10 Hz revealed fast synaptic depression,
showing that iN cell synapses exhibit short-term plasticity (Fig-
ure 4H). No inhibitory synaptic events were observed when
Ngn2-induced human iN cells were cocultured with glia cells,
but strong inhibitory synaptic inputs onto the iN cells were de-
tected when we cocultured iN cells with mouse cortical neurons
(Figures S4C–S4E). This experiment demonstrated that iN cells
integrate into a synaptic network with the mouse cortical
neurons and that they are fully capable of forming inhibitory post-
synaptic specializations. Quantifications showed that the vast
majority of all iN cells, when cocultured with mouse glia cells or
cortical neurons, contained voltage-gated Na+ and K+ currents,
exhibited spontaneous synaptic activity, and displayed evoked
EPSCs (Figure 4I).
Application of Human iN Cells to Study Normal and
Diseased Human Neurons
To explore the potential use of ESC- or iPSC-derived iN cells for
monitoring drug activities, studying human synaptic plasticity, or
modeling human disease states, we examined Ngn2 iN cells in a
variety of paradigms. We first tested the use of optogenetics to
directly probe the formation of presynaptic specializations of
iN cells onto cocultured mouse neurons (Figures 5A–5C). When
we selectively expressed the channelrhodopsin variant oChiEFtage of EGFP-positive cells that also express the neuronal marker MAP2 after 2
ells at the right. NeuN-positive cell yields are calculated both in terms of the
(light bars). For the latter, the yield exceeds 100% for H1-derived but not iPS-
s do not because they aremore sensitive to lentivirally induced cell death. Data
ure S2.
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foxp2 diencephalon
Ascl1 diencephalon
math3 diencephalon
tbx5 diencephalon
brn2 telencephalon
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lhx2 telencephalon
NeuroD1 telencephalon
Otx2 telencephalon
reelin telencephalon
RORB telencephalon
sox5 telencephalon
Tbr1 telencephalon
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TH dopaminergicn
foxo1 hindbrain
lbx1 hindbrain
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GRIA1 AMPA receptor
GRIA2 AMPA receptor
GRIA3 AMPA receptor
GRIA4 AMPA receptor
GRIN1 NMDA receptor
GRIN2A NMDA receptor
GRIN2B NMDA receptor
GABRA2 GABA receptor
GABRB1 GABA receptor
Gephyrin inhibitory synapses
vGlut1 glutamate transport
vGlut2 glutamate transport
vGAT GABA transport
GAD65 GABA synthesis
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KCNC1 potassium channel
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PSD−95 postsynaptic marker
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MAP2 pan−neuronal marker
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MIOX kidney
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nanog ES cell marker
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nestin NPC marker
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(legend on next page)
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Generation of Human Neurons for Synapse Analysisin iN cells and cocultured the iN cells with mouse neurons, we
found that this approach led to an accurate definition of presyn-
aptic function in the human iN cells that allows measurement of
synaptic transmission between two connected neurons without
the need to separately patch these neurons.
We then examined the possibility of monitoring activity-
dependent Ca2+ transients in entire populations of iN cells using
the genetically expressed Ca2+ sensor gCamp6M, which is an
advanced version of gCamp5 (Akerboom et al., 2012). We found
that Ca2+ transients induced even by single isolated action po-
tentials could be detected in our iN cells (Figure 5D). The ampli-
tude of the Ca2+ signal correlated well with the number of action
potentials elicited. Conversely, when we cocultured iN cells with
mouse neurons, we observed typical network activity in iN cells
that was induced by addition of the GABA-receptor blocker
picrotoxin (Figure 5E). These Ca2+ imaging examples de-
monstrate that it is possible to use iN cells for monitoring network
activity of iN cells over larger populations of cells, for example
during drug screening projects.
In another experiment, we tested whether synapses in Ngn2
produced iN cells can be modulated. Recent studies revealed
that retinoic acid rapidly upregulates postsynaptic AMPA-type
glutamate receptors via a direct synaptic action and that this
signaling pathway is activated by activity blockade (Aoto et al.,
2008; Wang et al., 2011). We thus explored the ability of
exogenously applied retinoic acid to upregulate postsynaptic
glutamate receptors (Figure 5F). Indeed, acute treatment
(45–90 min) of iN cells with retinoic acid significantly enhanced
the amplitude of postsynaptic mEPSCs that are mediated by
AMPA-type glutamate receptors without changing the frequency
of mEPSCs, demonstrating that the retinoic acid-dependent
synaptic signaling pathway is operational in iN cells and thus
also applies to humans. The effect was equally observed with
iN cells derived from H1 ESCs and with iN cells derived from
two different iPSC lines (Figures 5F and S5).
Finally, we examined whether iN cells can potentially be used
to monitor a disease state. We produced a knockdown (KD) of
Munc18-1, resulting in a 75% decrease in Munc18-1 mRNA
levels (Figure 5G). Heterozygous loss-of-function mutations of
Munc18-1 (gene symbol STXBP1) have been associated not
only with severe infantile epileptic encephalopathies (Ohtahara
and West syndromes), but also with moderate to severe cogni-
tive impairment and nonsyndromic epilepsy, suggesting that
the functions of human neurons are very sensitive to Munc18-1
levels (Pavone et al., 2012). Strikingly, KD of Munc18-1 in human
iN cells, such that Munc18-1 levels are decreased but not
abolished, led to a major decrease in the frequency but not the
amplitude of spontaneous EPSCs, which based on their size
probably represent mEPSCs (Figure 5H). Moreover, KD of
Munc18-1 caused a > 50% decrease in evoked EPSCs in iN
cells (Figure 5I). Thus, decreasing the Munc18-1 levels in humanFigure 3. iN Cell Generation Involves Reproducible Changes in Gene E
(A) Single-cell quantitative RT-PCR analysis (Fluidigm) of the expression levels of
color coded as shown on the bottom. mRNA levels were quantified in cytoplasm a
(B) Comparison of gene expression profiles in iN cells differentiated fromH1 ESC a
indicated at the bottom, with a cutoff of 27 cycles (on top of the 18 cycle pream
For more extensive analyses of further marker genes, see Figure S3.iN cells produces a major phenotype consistent with the delete-
rious phenotype observed in heterozygous loss-of-function
mutations observed in Ohtahara syndrome.
Functional Integration of Human iN Cells into Mouse
Brain
To probe the competence of Ngn2-induced iN cells to form syn-
apses in vivo and not only in vitro, we injected EGFP-labeled iN
cells on day 6 into the striatum of newborn mice (postnatal day 2)
and analyzed the mouse brains 6 weeks later.
Immunofluorescence staining revealed that the injected iN
cells had dispersed throughout the striatum and formed exten-
sivedendritic arborizations (Figure 6A).NumerousEGFP-positive
processes were found throughout the striatum and extending
through the corpus callosum into the nontransplanted hemi-
sphere. Thehuman iNcellswere selectively labeledbyantibodies
to human nuclei (Figure 6B), humanNCAM (Figure 6C), andNeuN
(Figure 6D). Electrophysiological recordings from acute slices
in current-clamp mode showed that the transplanted iN cells
exhibited a resting potential of 60 mV, fired trains of action
potentials when injectedwith current, and displayed a near phys-
iological action potential firing threshold and action potential
amplitude (Figures 6E and 6F). Moreover, recordings in voltage-
clamp mode demonstrated that the transplanted neurons
received highly active spontaneous inhibitory synaptic inputs
as documented by the blockade of the synaptic events by picro-
toxin (Figure 6G). Inhibitory synaptic events would be expected
given the preponderance of inhibitory medium spiny neurons in
the striatum. Accordingly, inhibitory postsynaptic currents could
also be elicited by extracellular stimulation, confirming that the
transplanted neurons received abundant inhibitory synaptic in-
puts from the surrounding neurons in the striatum (Figure 6H).
DISCUSSION
Previous studies demonstrated the principal feasibility of con-
verting nonneuronal human cells into iN cells but also described
a low conversion efficiency and a diminished capacity of the re-
sulting iN cells for synapse formation (Pang et al., 2011; Amba-
sudhan et al., 2011; Qiang et al., 2011; Pfisterer et al., 2011a,
2011b; Yoo et al., 2011; Caiazzo et al., 2011; Son et al., 2011).
However, realization of the potential of iN cells for studying the
pathogenesis of neurological diseases, for developing drug
screening systems, and for producing neurons for regenerative
medicine requires the capability of producing human iN cells at
a large scale and high yield and necessitates the generation of
iN cells that readily form synapses. Moreover, such goals would
be facilitated by a high degree of reproducibility of iN cell gener-
ation independent of the starting cell line and by production of a
relatively homogeneous population of functional iN cells for
experiments.xpression
the genes indicated on the right. Expression levels (expressed as Ct values) are
spirated from individual iN cells using patch pipettes after 3 weeks of induction.
nd two different lines of iPSCs. The plot depicts average Ct values of the genes
plification).
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Figure 4. iN Cells Derived from ESCs and
iPSCs Form Functional Synapses
(A) Representative traces of membrane currents
(upper panel) recorded following a ramp depolar-
ization protocol (lower panel). Na+ currents were
blocked by QX-314 (10 mM).
(B) Representative traces of whole-cell voltage-
clamp Na+ and K+ currents recorded in iN cells. iN
cells were subjected to 10 mV step de-
polarizations from90 mV to +50 mV at a70 mV
holding potential (pipette solution (in mM): 123
K-gluconate, 10 KCl, 1 MgCl2, 10 HEPES-KOH pH
7.2, 1 EGTA, 0.1 CaCl2, 1 K2ATP, 0.2 Na4GTP, and
4 glucose).
(C) Quantification of I/V curves of Na+ and K+
currents in iN cells derived fromH1 ESCs and from
two different iPSC lines. Data are means ± SEMs;
numbers of cells/cultures analyzed are shown in
the lower-right corner.
(D) Representative traces of spontaneous EPSCs
(likely mEPSCs based on size); middle panels
depict expansions of selected events. The lower
traces display block of spontaneous EPSCs by
50 mM CNQX.
(E and F) Representative traces of evoked EPSCs
monitored at 70 mV (E) and at +40 mV (F); lower
panels show that CNQX completely blocks all
EPSCs. Two superimposed traces are shown.
(G) Quantification of the frequency (left panel) and
amplitude of spontaneous EPSCs (middle panel)
and of the amplitude of evoked EPSCs (right
panel). Data are means ± SEM; numbers in the left
bars indicate the number of cells/independent
experiments performed, and apply to all panels.
Note that iN cells derived from different ESC/iPSC
lines exhibit quantitatively similar synaptic prop-
erties.
(H) Representative traces of EPSCs evoked by a
10 Hz stimulus train applied for 1 s and monitored
at 70 mV (top traces) and +40 mV (bottom
traces).
(I) Quantification of the rate of successful obser-
vations of voltage-gated Na+ currents, sponta-
neous EPSCs (sEPSCs), and evoked EPSCs
(eEPSCs) in iN cells. Numbers in top bars indicate
the number of cells/independent experiments
performed.
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Figure 5. Use of Rapidly Induced Human iN Cells for Characterizing Human Synapses and Modeling Human Diseases
(A–C) Optogenetic mapping of functional presynaptic specializations formed by iN cells onto cocultured cortical mouse neurons. (A) Strategy for the generation of
channelrhodopsin-expressing iN cells (top) and combined tdTomato fluorescence and DIC images (overview) or DIC images only (images of patched mouse
neurons and iN cells) to illustrate the selectively patching human iN cells or mouse neurons (bottom). ESCs were coinfected with lentivirus expressing the
channelrhodopsin variant oChiEF as a td-Tomato fusion protein at the time of Ngn2 transduction. (B) Synaptic responses triggered by presynaptic optogenetic
stimulation of iN cells and monitored in postsynaptic mouse neurons (top, representative traces; bottom, summary graph of the evoked EPSC amplitudes).
(legend continued on next page)
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Neuron
Generation of Human Neurons for Synapse AnalysisIn the present study, we describe a new, highly effective
method that generates a homogeneous population of iN cells
by forced expression of a single transcription factor in ESCs or
iPSCs. We demonstrate that the new method results in the
reproducible generation of the same type of neuron with quanti-
tatively the same properties independent of the ESC or iPSC line
used. The entire procedure generates iN cells in only a few
weeks, allowing a rapid turnaround of experiments, and the re-
sulting iN cells exhibit short-term plasticity, are modulated at
the level of their synapses, and integrate into neuronal networks
when transplanted into the mouse brain. Moreover, the new iN
cells can be used for studying synaptic properties including plas-
ticity, for large-scale Ca2+imaging (e.g., for drug screening pur-
poses), and for disease modeling as exemplified in our
Munc18-1 KD experiments. Thus, we believe that the approach
described here has the potential to enable mechanistic and
translational studies on human neurons that exceed currently ex-
isting capabilities and hope that the simplicity of the approach
will allow its wide dissemination. Table 1 shows a comparison
of the properties of the method described here with selected
other widely used methods to illustrate the advantages and
disadvantages of the various approaches that have been
described.
It is surprising that forced expression of a single transcription
factor can produce iN cells from human ESCs and iPSCs, sug-
gesting that this transcription factor alone initiates a specific
neuronal differentiation process. Previous experiments showed
that inmouse ESCs, expression of single transcription factors fa-
cilitates neuronal differentiation (e.g., see Hamada et al., 2006;
Kondo et al., 2008; Sugimoto et al., 2009), but the synaptic
competence of the resulting neuron-like mouse cells was not
assessed. Moreover, obtaining human iN cells has historically
been more challenging than obtaining mouse iN cells (Vierbu-
chen et al., 2010; Pang et al., 2011). It has been reported that
forced overexpression of Sox2 alone can convert mouse and hu-
man fibroblasts into NPCs (Ring et al., 2012), although our own
experiments required additional transcription factors besides
Sox2 for generation of NPCs (Lujan et al., 2012).
Exogenous Ngn2 probably induces neural differentiation by
activating a transcription factor cascade, including endogenous
Ngn2. Consistent with its embryonic expression in the devel-Responses were triggered by 3 ms blue light pulses without or with 0.5 mM TT
Channelrhodopsin-mediated presynaptic depolarizations monitored in human iN
EPSC). As in (B), responseswere triggered by light pulses in the absence or presen
induced by channelrhodopsin activation which is not inhibited by TTX.
(D and E) Ca2+ imaging of human iN cells. (D) Representative images of GCaMP
primary neurons (top) in the absence (left panels) or presence of a Ca2+ signal (right
potential (AP) inducing pulses were delivered at 50 Hz) or by network activity trig
bottom.
(F) iN cells derived from H1 ESCs or two different iPSC lines exhibit retinoic ac
plasticity. iN cells were incubated with 2 mMRA for 45–90 min, and the amplitude
are means ± SEMs. Statistical significance was assessed by Student’s t test (**p
(G–I) Effect of a Munc18-1 loss-of-function on synaptic transmission in human iN
Munc18-1 mRNA levels were measured by quantitative RT-PCR in conrol iN cells
an endogenous control (n = 3 independent experiments). (H) Representative trace
H1 ESCs (left), and quantifications of the frequency (center) and amplitudes of spo
are indicated. (I) Representative traces of evoked EPSCs of control and Munc18
EPSCs amplitudes (right). Numbers of cells/independent experiments performed
assessed by Student’s t test (*p < 0.05; ***p < 0.001).
794 Neuron 78, 785–798, June 5, 2013 ª2013 Elsevier Inc.oping dorsal forebrain, Ngn2 produced one particular type of
neuron that is characterized by specific markers, such as the
presence of vGlut2, Cux1, and Brn2, suggesting that it may
represent a relatively immature excitatory layer2/3 cortical
neuron. It is possible that single use of another transcription fac-
tor, or addition of other transcription factors to Ngn2 in our pro-
tocol, will result in other types of neurons as shown previously for
the BAM factor combination (Pfisterer et al., 2011b; Caiazzo
et al., 2011; Son et al., 2011).
We do not at present understandwhat determines the ability of
a neuron to form synapses. Most neuron-like cells can produce
action potentials and elaborate postsynaptic specializations—
even nonneuronal cells can be made to generate postsynaptic
specializations by simple expression of postsynaptic cell-adhe-
sionmolecules (Biederer et al., 2002)—but the ability to form pre-
synaptic specializations seems to be specific for a ‘‘real’’ neuron
(Yang et al., 2011). Ngn2-induced iN cells form robust synapses
among themselves when cultured in the presence of mouse as-
trocytes (which supply unknown synaptogenic factors) in a
manner that was not previously observed for any human iN cells
and occurs much faster than during conventional guided ESC/
iPSC differentiation approaches. The synapses that are thus
generated exhibit full function and are capable of short-term
plasticity and direct modulation by retinoic acid, suggesting
that Ngn2 iN cells provide a useful system for studies in which
the effects of mutations or pharmacological agents on synaptic
transmission in human neurons is investigated.
For the purpose of studying neurological diseases, the rela-
tively homogeneous nature of the iN cells we here generated
(which differs from the properties of neurons generated by
most other approaches; Table 1) is an advantage as well as a
disadvantage. It is advantageous in that phenotypes will not be
occluded by heterogeneous properties of different types of neu-
rons, but it might be disadvantageous if phenotypes that are
specific to a particular subset of neurons will be examined.
Thus, this system will be generally applicable to analysis of mu-
tations in genes with a general neuronal action, for example
FMRP, neuroligins, and MECP2. However, even for analysis of
diseases that manifest in specific types of neurons, such as
Parkinson’s disease, Ngn2 iN cells may be useful because in
many neurological diseases the pathological processes are notX (to block presynaptic action potentials induced by channelrhodopsin). (C)
cells (top, representative traces; bottom, summary graph of the light-evoked
ce of 0.5 mMTTX, but TTX has no effect because the recorded current is directly
6M-expressing iN cells cultured alone (top) or (E) of cocultured with cortical
panels). Traces of Ca2+ signals induced by field stimulation (D; indicated action
gered by 0.1 mM picrotoxin (E) monitored in these iN cells are shown on the
id (RA)-dependent increases in synaptic strength as a model of homeostatic
of spontaneous miniature EPSCs (mEPSCs) was recorded in TTX. Data shown
< 0.01; ***p < 0.001).
cells. (G) Quantification of the Munc18-1 knockdown (KD) efficiency in iN cells.
and iN cells infected with Munc18-1 KD lentivirus, and normalized to MAP2 as
s of spontaneous EPSCs monitored in control and Munc18-1 KD iN cells from
ntaneous EPSCs (right). Numbers of cells/ independent experiments performed
-1 KD iN cells derived from H1 cells (left), and quantification of spontaneous
are shown in the bars. Data are means ± SEMs; statistical significance was
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Figure 6. Functional Integration of Transplanted H1-Derived iN Cells into Mouse Brain
(A) Representative image of EGFP-expressing iN cells in mouse striatum. Note dispersion of the iN cells into the parenchyma (CC, corpus callosum; CTX, cortex;
LV, lateral ventricle; STR, striatum; scale bar: 200 mm).
(B) Labeling of the area in (A). with antibodies to the marker protein HuNu specific for human cells (scale bar: 200 mm).
(C) Morphology of a single EGFP- and human NCAM-positive iN cells after transplantation (scale bars: 20 mm and 10 mm [inset]).
(D) Example of an EGFP-positive human iN cell (left panel) that is colabeled with NeuN (right panel; scale bar: 20 mm).
(E) Example traces showing action potential generation (upper traces) in response to current pulses (lower traces) applied with 10 pA step sizes. For the recording
configuration from transplanted iN cells, see Figure S6.
(F) Average restingmembrane potential (Vrest), action potential threshold (Threshold), and action potential height (Height) measured in transplanted iN cells (n = 4,
left panel). Number of action potentials (AP #) plotted against current pulse values (n = 4, right panel).
(G) Representative traces of spontaneous postsynaptic inhibitory currents (IPSCs) monitored in transplanted iN cells; currents are blocked by picrotoxin.
(H) Evoked IPSCs elicited by extracellular stimulation (arrowhead) and blocked by addition of picrotoxin in transplanted iN cells.
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Generation of Human Neurons for Synapse Analysisrestricted to the specfiic types of neurons in which the disease
becomes manifest. Specifically, even if disease such as Parkin-
son’s or Huntington’s disease manifest in a dysfunction of dopa-
minergic or striatal neurons, respectively, this manifestation
probably represents a particular vulnerability of specific types
of neurons to a general disease process, and not a disease pro-
cess that is restricted to these types of neurons. Thus, even for
such diseases it may not only be feasible, but actually be pro-
ductive to examine Ngn2-generated iN cells as a homogeneous
population of glutamatergic neurons, especially in coculture with
mouse neurons or after transplantation into the mouse brain.
EXPERIMENTAL PROCEDURES
Cell Culture
H1 ESCs were obtained from WiCell Research Resources (Wicell, WI); the
iPS#1 line was derived from dermal fibroblasts of a Dystrophic epidermolysis
bullosa patient carrying homozygous mutations in COL7A1, while the iPS#2
line was derived from dermal fibroblast of a sickle cell anemia patient and
genetically corrected by homologous recombination (Sebastiano et al.,
2011). The type VII collagen gene is not expressed in neurons, patients with
mutations have no brain phenotypes, and our study demonstrates that themu-
tation of this gene does not affect the molecular and functional properties of
Ngn2-mediated iN cells. Both iPSC lines were generated by infecting with a
floxed polycistronic lentiviral reprogramming vector followed by Cre-mediated
loop-out of the reprogramming factors (Sommer et al., 2010). ESCs and iPSCs
were maintained as feeder-free cells in mTeSR1 medium (Stem Cell Technol-
ogies; Xu et al., 2010). Mouse glial cells were cultured from the forebrain of
newborn wild-type CD1 mice (Franke et al., 1998). Briefly, newborn mouse
forebrain homogenates were digested with papain and EDTA for 30 min, cells
were dissociated by harsh trituration to avoid growing of neurons, and plated
onto T75 flasks in DMEM supplemented with 10%FBS. Upon reaching conflu-
ence, glial cells were trypsinized and replated at lower density a total of three
times to remove potential trace amounts of mouse neurons before the glia cell
cultures were used for coculture experiment with iN cells. Mouse cortical neu-
rons were cultured as described (Pang et al., 2011), added to iN cells 4–5 days
after infection, and cocultured for an additional 2 weeks.
Virus Generation
Lentiviruses were produced as described (Pang et al., 2010) in HEK293T cells
(ATCC, VA) by cotransfection with three helper plasmids (pRSV-REV, pMDLg/
pRRE and vesicular stomatitis virus G protein expression vector) (12 mg of len-
tiviral vector DNA and 6 mg of each of the helper plasmid DNA per 75 cm2 cul-
ture area) using calcium phosphate (Chen and Okayama, 1987). Lentiviruses
were harvested with the medium 46 hr after transfection, pelleted by centrifu-
gation (49,000 3 g for 90 min), resuspended in MEM, aliquoted, and snap-
frozen in liquid N2. Only virus preparations with > 90% infection efficiency as
assessed by EGFP expression or puromycin resistance were used for exper-
iments. For details of lentiviral constructs, see Supplemental Experimental
Procedures.
Generation of iN Cells from Human ESCs and iPSCs
ESCs and iPSCs were treated with Accutase (Innovative Cell Technologies)
and plated as dissociated cells in 24-well plates (H1: 13 104 cells/well; iPSCs:
1.5 3 104 cells/well) on day 2 (Figure 1B). Cells were plated on matrigel (BD
Biosciences)-coated coverslips in mTeSR1 containing 2 mM thiazovivin (Bio
Vision). On day 1, lentivirus prepared as described above (0.3 ml/well of
24-well plate) was added in fresh mTeSR1 medium containing polybrene
(8 mg/ml, Sigma). On day 0, the culture medium was replaced with N2/
DMEM/F12/NEAA (Invitrogen) containing human BDNF (10 mg/l, PeproTech),
human NT-3 (10 mg/l, PeproTech), and mouse laminin (0.2 mg/l, Invitrogen).
Doxycycline (2 g/l, Clontech) was added on day 0 to induce TetO gene
expression and retained in the medium until the end of the experiment. On
day 1, a 24 hr puromycin selection (1 mg/l) period was started. On day 2,
mouse glia cells were added in Neurobasal medium supplemented with796 Neuron 78, 785–798, June 5, 2013 ª2013 Elsevier Inc.B27/Glutamax (Invitrogen) containing BDNF and NT3; Ara-C (2 g/l, Sigma)
was added to the medium to inhibit astrocyte proliferation. After day 2, 50%
of the medium in each well was exchanged every 2 days. FBS (2.5%) was
added to the culture medium on day 10 to support astrocyte viability, and iN
cells were assayed on day 14 or 21 in most experiments. The efficiency of con-
version of ESCs and iPSCs into iN cells was calculated by two approaches
fromcounts of cell densities in four randomfields on each coverslip (Figure 2D):
(1) as the percentage of EGFP-positive lentivirally transduced cells that also
express MAP2 or NeuN; (2) as the percentage of starting cells that become
NeuN positive.
Immunofluorescence Experiments
Immunofluorescence experiments were performed essentially as described
(Pang et al., 2011). Briefly, cultured iN cells were fixed in 4%paraformaldehyde
in PBS for 20 min at room temperature, washed three times with PBS, and
incubated in 0.2% Triton X-100 in PBS for 10 min at room temperature. Cells
were blocked in PBS containing 10% goat serum for 1 hr at room temperature.
Primary antibodies were applied overnight, cells were washed in PBS for three
times and blocked with 10% goat serum for 15 min, secondary antibodies
were applied for 1 hr. Transplanted iN cells in mouse striatum were analyzed
by immunofluorescence staining after mice were transcardially perfused
with saline followed by 4% paraformaldehyde. After overnight postfixation,
brains were removed, cryoprotected in 30% sucrose, and cut in 40 mm thick
coronal sections. Free-floating sections were washed in PBS, incubated
with PBS containing 0.25% Triton X-100 and 5% FBS for 1hr and stained over-
night with primary antibodies. Following washes, sections were incubatedwith
secondary antibodies for 2 hr, washed, mounted on glass slides and coverslip-
ped. For antibody details, see Supplemental Experimental Procedures.
Gene Expression Analyses
For quantitative RT-PCR analyses of pooled cultured cells, RNA was isolated
using the RNAqueous Kit (Applied Biosystems), treated with DNase (Applied
Biosystems), and reverse transcribed with Superscript III (Invitrogen). mRNA
levels were quantified by real-time PCR assay using the Applied Biosystems
7900HT Fast real-time PCR system and RQ analysis software. For quantitative
RT-PCR analyses of single cells, cytoplasm from individual cells was aspirated
with a patch pipette, and mRNA levels were measured in the cytoplasm using
the Fluidigm Biomark dynamic array system as described (Pang et al., 2011).
For all quantitative RT-PCR assays, titrations of total human brain RNA were
included in each experiment, and only primers that demonstrated a linear
amplification with R2 values of > 0.98 were included (see Supplemental Infor-
mation and Table S1 for details).
RNAi Experiments
Oligonucleotides containing the human Munc18-1 shRNA sequence (GGCA
CAGATGCTGAGGGAGAG) were cloned into the XhoI/XbaI cloning site down-
stream of the human H1 promoter in the L309-mCherry lentiviral vector (Yang
et al., 2011). Lentiviruses for control (no shRNA) and the Munc18-1 KD were
prepared as described above and used to infect H1-iN cells 5 days after doxy-
cycline addition. iN cells were analyzed at 3 weeks after Ngn2 induction by
determining the KD efficacy using RT-PCR and by electrophysiology.
Ca2+ Imaging Experiments
Ca2+ imaging experiments were performedwith iN cells that were infected with
a lentivirus expressing GCaMP6M on day 3 after induction, cocultured with
mouse cortical neurons at day 6 after induction, and analyzed at day 21.
See Supplemental Information for details.
Channelrhodopsin Experiments
H1 cells were coinfected with viruses expressing Ngn2 and oChiEF-tdTomato
on day 1, and mouse cortical neurons were added for coculture on day 3.
iN cells were analyzed at day 21 as described in detail in the Supplemental
Experimental Procedures.
Transplantation
H1-derived iN cells were dissociated using Enzyme-Free Cell Dissociation
Buffer (GIBCO) 7 days after infection (i.e., on day 6) without coculture of
Neuron
Generation of Human Neurons for Synapse Analysisastrocytes, and 105 cells were unilaterally injected under hypothermia-induced
anesthesia into the striatum of postnatal day 2 NOD-SCID; IL2Rg knockout
mice. Mice were processed for immunocytochemistry or slice electrophysi-
ology 6 weeks after transplantation.
Electrophysiology
Electrophysiology of cultured iN cells was performed essentially as described
(Maximov and Su¨dhof, 2005; Pang et al., 2011). Stimulus artifacts for evoked
synaptic responses were removed for graphic representation. For electro-
physiological recordings of transplanted cells, we prepared acute coronal sli-
ces (140 mm) of striatum frommice 6 weeks after transplantation using a vibra-
tome (Leica, VT1200 S). GFP-positive hES-iN cells in slices were visualized
using an X-cite 120Q fluorescence lamp (Lumen Dynamics) and an Olympus
BX51WI microscope equipped with a Rolera-XR camera (Qimaging). Whole-
cell patches were established at room temperature using MPC-200 manipula-
tors (Sutter Instrument) and Multiclamp 700B amplifier (Molecular Devices)
controlled by Clampex 10 Data Acquisition Software (Molecular Devices).
Cells were recorded in current-clamp mode for intrinsic firing properties and
switched to voltage-clamp mode (70 mV) for synaptic measurements.
Evoked responses were generated using a concentric bipolar electrode
(FHC) connected to Isolated Pulse Stimulator 2100 (A-M systems). Picrotoxin
(50 mM, Tocris) was used to block inhibitory synaptic responses. For more de-
tails, see Supplemental Experimental Procedures.
Data Presentation and statistics
All data shown are means ± SEMs; all statistical analyses were performed us-
ing Student’s t test comparing the test sample to the control sample examined
in the same experiments.
Miscellaneous
All animal experiments for the present study were performed with approval of
the Stanford IACUC.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.neuron.2013.05.029.
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